Unknown

Dataset Information

0

YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma.


ABSTRACT: Novel drugs targeting Wnt signaling are gradually being developed for hepatocellular carcinoma (HCC) treatment. In this study, we used a Wnt-responsive Super-TOPflash (STF) luciferase reporter assay to screen a new compound targeting Wnt signaling. 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) was identified as a small molecule inhibitor of the Wnt/β-catenin pathway. Our coimmunoprecipitation (co-IP) data showed that YC-1 did not affect the β-catenin/TCF interaction. Then, by mass spectrometry, we identified the ErbB3 receptor-binding protein 1 (EBP1) interaction with the β-catenin/TCF complex upon YC-1 treatment. EBP1 encodes two splice isoforms, p42 and p48. We further demonstrated that YC-1 enhances p42 isoform binding to the β-catenin/TCF complex and reduces the transcriptional activity of the complex. The suppression of colony formation by YC-1 was significantly reversed after knockdown of both isoforms (p48 and p42); however, the inhibition of colony formation was maintained when only EBP1 p48 was silenced. Taken together, these results suggest that YC-1 treatment results in a reduction in Wnt-regulated transcription through EBP1 p42 and leads to the inhibition of tumor cell proliferation. These data imply that YC-1 is a drug that antagonizes Wnt/β-catenin signaling in HCC.

SUBMITTER: Wu JY 

PROVIDER: S-EPMC6562864 | biostudies-other | 2019 May

REPOSITORIES: biostudies-other

altmetric image

Publications

YC-1 Antagonizes Wnt/β-Catenin Signaling Through the EBP1 p42 Isoform in Hepatocellular Carcinoma.

Wu Ju-Yun JY   Shih Yu-Lueng YL   Lin Shih-Ping SP   Hsieh Tsai-Yuan TY   Lin Ya-Wen YW  

Cancers 20190513 5


Novel drugs targeting Wnt signaling are gradually being developed for hepatocellular carcinoma (HCC) treatment. In this study, we used a Wnt-responsive Super-TOPflash (STF) luciferase reporter assay to screen a new compound targeting Wnt signaling. 3-(5'-Hydroxymethyl-2'-furyl)-1-benzylindazole (YC-1) was identified as a small molecule inhibitor of the Wnt/β-catenin pathway. Our coimmunoprecipitation (co-IP) data showed that YC-1 did not affect the β-catenin/TCF interaction. Then, by mass spectr  ...[more]

Similar Datasets

| S-EPMC11307499 | biostudies-literature
| S-EPMC4694839 | biostudies-other
| S-EPMC3084683 | biostudies-literature
| S-EPMC3072412 | biostudies-literature
| S-EPMC7431544 | biostudies-literature
| S-EPMC5342721 | biostudies-literature
| S-EPMC11319953 | biostudies-literature
| S-EPMC4641324 | biostudies-literature
| S-EPMC5623973 | biostudies-literature
| S-EPMC2993678 | biostudies-literature